Dorsey Wright & Associates Acquires New Shares in Tenet Healthcare Corporation $THC

Dorsey Wright & Associates bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 54,095 shares of the company’s stock, valued at approximately $10,750,000. Tenet Healthcare comprises 2.3% of Dorsey Wright & Associates’ investment portfolio, making the stock its 10th largest holding.

Several other hedge funds have also recently modified their holdings of THC. Price T Rowe Associates Inc. MD raised its position in Tenet Healthcare by 1.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after buying an additional 119,809 shares during the last quarter. Boston Partners grew its stake in shares of Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock worth $723,804,000 after acquiring an additional 494,581 shares during the period. AQR Capital Management LLC raised its holdings in shares of Tenet Healthcare by 20.3% during the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock valued at $448,419,000 after purchasing an additional 380,116 shares during the last quarter. Ameriprise Financial Inc. lifted its position in Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after purchasing an additional 157,109 shares during the period. Finally, Norges Bank purchased a new stake in Tenet Healthcare in the fourth quarter worth approximately $248,494,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.97% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on THC shares. KeyCorp decreased their target price on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Wells Fargo & Company cut their price objective on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Robert W. Baird lowered their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a research report on Friday, May 1st. Finally, Barclays reduced their price target on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Eighteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $172.63 on Friday. The stock has a market cap of $14.87 billion, a P/E ratio of 8.98, a P/E/G ratio of 1.47 and a beta of 1.28. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The stock’s fifty day moving average is $183.00 and its 200 day moving average is $198.73. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter in the prior year, the business posted $4.36 earnings per share. The business’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.